+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Bioconjugation Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bioconjugation Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 182 Pages
  • Global
From
From
The Biosimilars Landscape in Japan: 2009-2020 Study - Product Thumbnail Image

The Biosimilars Landscape in Japan: 2009-2020 Study

  • Report
  • January 2020
  • 156 Pages
  • Japan
From
From
Angiopoietin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Angiopoietin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
From
Biotech Ingredient Market Report 2026 - Product Thumbnail Image

Biotech Ingredient Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Biotechnology Services Market Report 2026 - Product Thumbnail Image

Biotechnology Services Market Report 2026

  • Report
  • January 2026
  • 250 Pages
  • Global
From
Rare Diseases Market Report 2024-2034 - Product Thumbnail Image

Rare Diseases Market Report 2024-2034

  • Report
  • May 2024
  • 344 Pages
  • Global
From
Loading Indicator